BMO Capital raised the firm’s price target on Fiserv (FI) to $260 from $233 and keeps an Outperform rating on the shares. The company reported

Co. Inc. (NYSE:MRK), reducing the pharmaceutical giant's price target from $105.00 to $96.00, while keeping a Market Perform rating on the stock. Analysts at BMO Capital cited a decrease in confidence stemming from recent shifts in expectations for Merck's vaccine,

BMO Capital Markets has recently initiated Aflac Inc (AFL) stock to Market Perform rating, as announced on January 23, 2025, according to Finviz. Earlier, on October 9, 2024, TD Cowen had initiated the stock to Hold,

BMO Capital analyst Bhavesh Lodaya lowered the firm’s price target on Olin (OLN) to $34 from $44 and keeps a Market Perform rating on the

BMO Capital Markets sustained its optimistic outlook on Snap Inc (NYSE:SNAP), reaffirming an Outperform rating with a steady price target of $16.00. Currently trading at $11.60, with a market capitalization of $19.